A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

Yeh, Elizabeth, Cunningham, Melissa, Arnold, Hugh, Chasse, Dawn, Monteith, Teresa, Ivaldi, Giovanni, Hahn, William C., Stukenberg, P. Todd +6 more·2004·Nature Cell Biology

Cited by (796)

Items 101–200 of 796

  1. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4
    Jinhai Li, Yuanyuan Guo, Xiao-Di Liang, Ming Sun, Guo‐Liang Wang, Wei De, WU Wen-xi · 2012 · Journal of Cancer Research and Clinical Oncology
  2. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1
    Matteo Moretto-Zita, Hua Jin, Zhouxin Shen, Tongbiao Zhao, Steven P. Briggs, Yang Xu · 2010 · Proceedings of the National Academy of Sciences
  3. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis
    Ke Jin, Shufei Wang, Yazhuo Zhang, Mengfang Xia, Yongzhen Mo, Xiaoling Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Yi He · 2019 · Cellular and Molecular Life Sciences
  4. CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis
    Qianze Dong, Yang Wang, Xin-Jun Dong, Zixuan Li, Zhongping Tang, Quan‐Ze Cui, Enhua Wang · 2010 · Annals of Surgical Oncology
  5. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
    Jie Wang, Jongchan Kim, Meejeon Roh, Omar E. Franco, Simon W. Hayward, Marcia L. Wills, Sarki Abba Abdulkadir · 2010 · Oncogene
  6. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors
    Francesco Marampon, Carmela Ciccarelli, BIANCA MARIA ZANI · 2006 · Molecular Cancer
  7. Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
    Brittany L. Allen-Petersen, Rosalie C. Sears · 2019 · BioDrugs
  8. The Cdk1 Complex Plays a Prime Role in Regulating N-Myc Phosphorylation and Turnover in Neural Precursors
    Sarah K. Sjostrom, Greg Finn, William C. Hahn, David H. Rowitch, Anna Marie Kenney · 2005 · Developmental Cell
  9. Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis
    Amy S. Farrell, Carl Pelz, Xiaoyan Wang, Colin J. Daniel, Zhiping Wang, Yulong Su, Mahnaz Janghorban, Xiaoli Zhang, Charles W. Morgan, Soren Impey et al. · 2013 · Molecular and Cellular Biology
  10. Mechanisms of MYC stabilization in human malignancies
    Melissa R. Junttila, Jukka K. Westermarck · 2008 · Cell Cycle
  11. The broken “Off” switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance
    Ruvolo, Peter P. · 2016 · BBA Clinical
  12. Protein phosphatase 2A regulatory subunits and cancer
    Eichhorn, Pieter J.A., Creyghton, Menno P., Bernards, René · 2009 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  13. MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
    Amy S. Farrell, Meghan M. Joly, Brittany L. Allen-Petersen, Patrick Joseph Worth, Christian Lanciault, David Sauer, Jason M. Link, Carl Pelz, Laura M. Heiser, Jennifer P. Morton et al. · 2017 · Nature Communications
  14. Update on Human Polyomaviruses and Cancer
    Ole V. Gjoerup, Yuan Chang · 2010 · Advances in cancer research
  15. Adiponectin-Activated AMPK Stimulates Dephosphorylation of AKT through Protein Phosphatase 2A Activation
    Kun-yong Kim, Ahmi Baek, Ji-Eun Hwang, Yeon A. Choi, Joon Jeong, Myeong-Sok Lee, Dea Ho Cho, Jong‐Seok Lim, Keun Il Kim, Young Duk Yang · 2009 · Cancer Research
  16. Merkel Cell Polyomavirus Large T Antigen Has Growth-Promoting and Inhibitory Activities
    Jingwei Cheng, Orit Rozenblatt–Rosen, Kelly Garneski Paulson, Paul Nghiem, James A. DeCaprio · 2013 · Journal of Virology
  17. Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis
    Jue Jiang, Jingchao Wang, Ming Yue, Xiaolian Cai, Tianci Wang, Chao Wu, Hexiu Su, Yanwu Wang, Meng Han, Yingchi Zhang et al. · 2020 · Cancer Cell
  18. Tumor Suppression by the Mammalian Period Genes
    Cheng Chi Lee · 2006 · Cancer Causes & Control
  19. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models
    Silvestre Vicent, Chen Ron, Leanne C. Sayles, Chenwei Lin, Randal G. Walker, Anna K. Gillespie, Aravind Subramanian, Gregory Hinkle, Xiaoping Yang, Sakina Saif et al. · 2010 · Journal of Clinical Investigation
  20. Proteolytic Control of the Oncoprotein Transcription Factor Myc
    Lance R. Thomas, William P. Tansey · 2011 · Advances in cancer research
  21. The Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Stabilizes and Activates c-Myc
    Jianyong Liu, Heather J. Martin, Gangling Liao, S. Diane Hayward · 2007 · Journal of Virology
  22. Immortalization of Primary Human Prostate Epithelial Cells by c-Myc
    Jesús Gil, Preeti Kerai, Matilde Esther LLeonart, David Bernard, Juan C. Cigudosa, Gordon G. Peters, Amancio Carnero, David Beach · 2005 · Cancer Research
  23. Ceramide induced mitophagy and tumor suppression
    Mohammed Dany, Besim Öğretmen · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  24. New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK
    Giuseppe Barone, John Anderson, Andrew D.J. Pearson, Kevin R. Petrie, Louis Chesler · 2013 · Clinical Cancer Research
  25. Complex regulatory mechanisms mediated by the interplay of multiple post-translational modifications
    Veronika Csizmók, Julie Deborah Forman-Kay · 2017 · Current Opinion in Structural Biology
  26. Targeting PP2A in cancer: Combination therapies
    Sahar Mazhar, Sarah E. Taylor, Jaya Sangodkar, Goutham Narla · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  27. Myc and its interactors take shape
    William B. Tu, Sara Helander, Robert Pilstål, K. Ashley Hickman, Corey Lourenco, Igor Jurišica, Brian Raught, Björn Wallner, Maria Sunnerhagen, Linda Z. Penn · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  28. Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
    Kauko, Otto, Westermarck, Jukka · 2018 · The International Journal of Biochemistry & Cell Biology
  29. miR-18, a member of Oncomir-1, targets heat shock transcription factor 2 in spermatogenesis
    Johanna Björk, Anton Sandqvist, Alexandra N. Elsing, Noora Kotaja, Lea Sistonen · 2010 · Development
  30. Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding
    Cecilia Andrésen, Sara Helander, Alexander S. Lemak, Christophe Farès, Veronika Csizmók, Jonas Carlsson, Linda Z. Penn, Julie Deborah Forman-Kay, C.H. Arrowsmith, Patrik Lundström et al. · 2012 · Nucleic Acids Research
  31. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential
    Christopher S. Hong, Winson S. Ho, Chao Zhang, Chunzhang Yang, James Bradley Elder, Zhuang Zhengping · 2015 · Cancer Biology & Therapy
  32. B55β-Associated PP2A Complex Controls PDK1-Directed Myc Signaling and Modulates Rapamycin Sensitivity in Colorectal Cancer
    Jing Ying Tan, Puay Leng Lee, Zhimei Li, Xia Jiang, Yaw Chyn Lim, Shing Chuan Hooi, Qiang Yu · 2010 · Cancer Cell
  33. Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
    Liu, Zhaoqi, Yoshimi, Akihide, Wang, Jiguang, Cho, Hana, Chun-Wei Lee, Stanley, Ki, Michelle, Bitner, Lillian, Chu, Timothy, Shah, Harshal, Liu, Bo et al. · 2020 · Cancer Discovery
  34. O-GlcNAcylation and Metabolic Reprograming in Cancer
    PaweÅ‚ Jà Åowiak, Ewa Forma, Magdalena Bryś, Anna Krześlak · 2014 · Frontiers in Endocrinology
  35. Pin1 Regulates Centrosome Duplication, and Its Overexpression Induces Centrosome Amplification, Chromosome Instability, and Oncogenesis
    Futoshi Suizu, Akihide Ryo, Gerburg M. Wulf, Jormay Lim, Kun Ping Lu · 2006 · Molecular and Cellular Biology
  36. The Axin1 scaffold protein promotes formation of a degradation complex for c‐Myc
    Hugh Arnold, Xiaoli Zhang, Colin J. Daniel, Deanne Tibbitts, Julienne R. Escamilla‐Powers, Amy Farrell, Sara A. Tokarz, Charles W. Morgan, Rosalie C. Sears · 2009 · The EMBO Journal
  37. Fbw7/hCDC4 dimerization regulates its substrate interactions.
    Markus Welcker, Bruce E. Clurman · 2007 · Cell Division
  38. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance
    Nasser Samadi, Raie Bekele, Dora Capatos, Ganesh Venkatraman, Meltem Sarıahmetoğlu, David N. Brindley · 2010 · Biochimie
  39. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen
    Darya Bubman, Ilaria Guasparri, Ethel Cesarman · 2007 · Oncogene
  40. Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
    Farrell, Amy S., Allen-Petersen, Brittany, Daniel, Colin J., Wang, Xiaoyan, Wang, Zhiping, Rodriguez, Sarah, Impey, Soren, Oddo, Jessica, Vitek, Michael P., Lopez, Charles et al. · 2014 · Molecular Cancer Research
  41. Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
    Danilo Perrotti, Paolo Neviani · 2008 · Cancer and Metastasis Reviews
  42. Regulation of the Warburg Effect in Early-Passage Breast Cancer Cells
    Ian Robey, Renu M. Stephen, Kathy S. Brown, Brenda K. Baggett, Robert A. Gatenby, Robert J. Gillies · 2008 · Neoplasia
  43. Ubiquitylation of Cyclin E Requires the Sequential Function of SCF Complexes Containing Distinct hCdc4 Isoforms
    Frank van Drogen, Olle Sangfelt, Alena Malyukova, Liudmila V. Matskova, Elizabeth Shinmay Yeh, Anthony R. Means, Steven I. Reed · 2006 · Molecular Cell
  44. A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins
    Arnold, Hugh K., Sears, Rosalie C. · 2008 · Cancer and Metastasis Reviews
  45. Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression
    Madhura R. Pandkar, Sommya Sinha, Atul Samaiya, Sanjeev Shukla · 2023 · Translational Oncology
  46. Alteration of host cell phenotype by Theileria annulata and Theileria parva: mining for manipulators in the parasite genomes
    Brian R Shiels, Gordon Langsley, William Weir, Arnab Pain, Sue McKellar, Dirk A. E. Dobbelaere · 2005 · International Journal for Parasitology
  47. Mutations in NEXN, a Z-Disc Gene, Are Associated with Hypertrophic Cardiomyopathy
    Hu Wang, Zhaohui Li, Jizheng Wang, Kai Sun, Qiqiong Cui, Lei Song, Yubao Zou, Xiaojian Wang, Xuan Liu, Rutai Hui et al. · 2010 · The American Journal of Human Genetics
  48. Subcellular Localization of Glycogen Synthase Kinase 3β Controls Embryonic Stem Cell Self-Renewal
    Matthew E. Bechard, Stephen Dalton · 2009 · Molecular and Cellular Biology
  49. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3β/FBW7 loss of function
    Sabine Rottmann, Yan Wang, Marc S. Nasoff, Quinn L. Deveraux, Kim C. Quon · 2005 · Proceedings of the National Academy of Sciences
  50. A Network of Genetic Events Sufficient to Convert Normal Human Cells to a Tumorigenic State
    Sara Kendall, Corinne Mary Linardic, Stacey J. Adam, Christopher M. Counter · 2005 · Cancer Research
  51. Chaperone-mediated autophagy prevents cellular transformation by regulating MYC proteasomal degradation
    Luciana Rodrigues Gomes, Carlos Frederico Martins Menck, Ana María Cuervo · 2017 · Autophagy
  52. Ambra1 at a glance
    Valentina Cianfanelli, Daniela De Zio, Sabrina Di Bartolomeo, Francesca Nazio, Flavie Strappazzon, Francesco Cecconi · 2015 · Journal of Cell Science
  53. The PKB/FOXO switch in aging and cancer
    David E.A. Kloet, Boudewijn M.T. Burgering · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  54. Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56
    Wang, Jiao, Okkeri, Juha, Pavic, Karolina, Wang, Zhizhi, Kauko, Otto, Halonen, Tuuli, Sarek, Grzegorz, Ojala, Päivi M, Rao, Zihe, Xu, Wenqing et al. · 2017 · The EMBO Reports
  55. MYC function and regulation in physiological perspective
    Rajeev Jha, Fedor Kouzine, David Levens · 2023 · Frontiers in Cell and Developmental Biology
  56. Pin1 Down-regulates Transforming Growth Factor-β (TGF-β) Signaling by Inducing Degradation of Smad Proteins
    Ayako Nakano, Daizo Koinuma, Keiji Miyazawa, Takafumi Uchida, Masao Saitoh, Masahiro Kawabata, Jun-ichi Hanai, Hirotada Akiyama, Masahiro Abe, Kohei Miyazono et al. · 2009 · Journal of Biological Chemistry
  57. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma
    S -G Lee, Hyerin Jeon, Zhao Zhong Su, Joanna E. Richards, Nicollaq Vozhilla, Devanand Sarkar, Tom Van Maerken, Paul B. Fisher · 2009 · Oncogene
  58. Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
    Ana Maria Gonzalez-Angulo, Bryan T. Hennessy, Funda Meric‐Bernstam, Ayşegül A. Şahin, Wenbin Liu, Zhenlin Ju, Mark Stafford Carey, Simen Myhre, Corey Wayne Speers, Lei Deng et al. · 2011 · Clinical Proteomics
  59. Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer
    Laura M. Beaver, Rachael Kuintzle, Alex Buchanan, Michelle W. Wiley, Sarah T Glasser, Carmen P. Wong, Gavin S. Johnson, Jeff H. Chang, Christiane V. Löhr, David E. Williams et al. · 2017 · The Journal of Nutritional Biochemistry
  60. MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer
    Jingyan Yi, Chongya Liu, Zhiwei Tao, Min Wang, Yaxun Jia, Xiaolin Sang, Lanlin Shen, Yijue Xue, Kui Jiang, Fuwen Luo et al. · 2019 · EBioMedicine
  61. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells
    Laura Rosa Mangiapane, Annalisa Nicotra, Alice Turdo, Miriam Gaggianesi, Paola Bianca, Simone Di Franco, Davide Stefano Sardina, Veronica Veschi, Michele Signore, Sven Beyes et al. · 2021 · Gut
  62. The Fbxw7/hCdc4 tumor suppressor in human cancer
    YingMeei Tan, Olle Sangfelt, Charles Spruck · 2008 · Cancer Letters
  63. Oncogenic potentials of the human polyomavirus regulatory proteins
    Ugo Lionel Moens, Marijke Van Ghelue, Mona Johannessen · 2007 · Cellular and Molecular Life Sciences
  64. Emerging role of aging in the progression of NAFLD to HCC
    Yongyuan He, Yinghong Su, Chengcheng Duan, Siyuan Wang, Wei Guo He, Yingting Zhang, Xiaofei An, Ming He · 2022 · Ageing Research Reviews
  65. The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability
    Elizabeth Shinmay Yeh, Brian O. Lew, Anthony R. Means · 2005 · Journal of Biological Chemistry
  66. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma
    Francesco Marampon, Gianluca Bossi, Carmela Ciccarelli, Agnese Di Rocco, Ada Sacchi, Richard G. Pestell, BIANCA MARIA ZANI · 2009 · Molecular Cancer Therapeutics
  67. PP2A-B′ holoenzyme substrate recognition, regulation and role in cytokinesis
    Wu, Cheng-Guo, Chen, Hui, Guo, Feng, Yadav, Vikash K, Mcilwain, Sean J, Rowse, Michael, Choudhary, Alka, Lin, Ziqing, Li, Yitong, Gu, Tingjia et al. · 2017 · Cell Discovery
  68. The Role of Decorin and Biglycan Signaling in Tumorigenesis
    Valentina Diehl, Lisa Sophie Huber, Jonel Trebicka, Małgorzata Wygrecka, Renato V. Iozzo, Liliana Schaefer · 2021 · Frontiers in Oncology
  69. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression
    Mitsuko Iiyama, Kazuhiko Kakihana, Tetsuya Kurosu, Osamu Miura · 2005 · Cellular Signalling
  70. An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
    Mélanie Mahé, Florent Dufour, Hélène Neyret‐Kahn, Aura Ileana Moreno-Vega, C Béraud, Mingjun Shi, Imène Hamaidi, Virginia Sánchez‐Quiles, Clémentine Krucker, Marion Dorland‐Galliot et al. · 2018 · EMBO Molecular Medicine
  71. Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells
    Ryan T. Phan, Masumichi Saito, Yukiko Kitagawa, Anthony R. Means, Riccardo Dalla‐Favera · 2007 · Nature Immunology
  72. Some p53-binding proteins that can function as arbiters of life and death
    Antony W. Braithwaite, Giannino Del Sal, Xin Lü · 2006 · Cell Death and Differentiation
  73. Coumarins and Lignans from Zanthoxylum schinifolium and Their Anticancer Activities
    Wei Li, Ya Nan Sun, Xi Yan, Seo Young Yang, Eun‐Ji Kim, Hee Kyoung Kang, Young Ho Kim · 2013 · Journal of Agricultural and Food Chemistry
  74. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells
    Chun Chou, Amelia K. Pinto, Jonathan D. Curtis, Stephen P. Persaud, Marina Cella, Chih‐Chung Lin, Brian T. Edelson, Paul M. Allen, Marco Colonna, Erika L. Pearce et al. · 2014 · Nature Immunology
  75. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
    Suman Malempati, Deanne Tibbitts, M Cunningham, Yassmine M. N. Akkari, Susan B. Olson, Gaofeng Fan, Rosalie C. Sears · 2006 · Leukemia
  76. SV40 small T antigen and PP2A phosphatase in cell transformation
    Anna A. Sablina, William C. Hahn · 2008 · Cancer and Metastasis Reviews
  77. Degradation of the Tumor Suppressor PML by Pin1 Contributes to the Cancer Phenotype of Breast Cancer MDA-MB-231 Cells
    Erin L. Reineke, Minh C. Lam, Qing Liu, Yu Liu, Kristopher J. Stanya, Kun-Sang Chang, Anthony R. Means, Hung‐Ying Kao · 2007 · Molecular and Cellular Biology
  78. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation
    Yong Liao, YinYin Wei, Xiaofei Zhou, J -Y Yang, Chengkai Dai, Y J Chen, Nitin Agarwal, Dos D. Sarbassov, Da Shi, Dihua Yu et al. · 2009 · Oncogene
  79. Preventing the Degradation of Mps1 at Centrosomes Is Sufficient to Cause Centrosome Reduplication in Human Cells
    Christopher Kasbek, Ching-Hui Yang, Adlina Mohd Yusof, Heather M. Chapman, Mark Winey, Harold A. Fisk · 2007 · Molecular Biology of the Cell
  80. Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways
    Katarzyna Walczak, Waldemar Andrzej Turski, Grazyna Rajtar · 2014 · Amino Acids
  81. Ribosomal Protein S14 Negatively Regulates c-Myc Activity
    Xiang Yu Zhou, Qian Hao, Jun‐Ming Liao, Peng Liao, Hua Lu · 2013 · Journal of Biological Chemistry
  82. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
    Audrey Bouillez, Hasan N. Rajabi, Sean P. Pitroda, Caining Jin, Maroof Alam, Akriti Kharbanda, Ashujit Tagde, Kwok‐Kin Wong, Donald W. Kufe · 2016 · Cancer Research
  83. Isolation and identification of aromatic compounds in Lion’s Mane Mushroom and their anticancer activities
    Wei Li, Wei Ping Zhou, Eun-Ji Kim, Sang Hee Shim, Hee Kyoung Kang, Young Ho Kim · 2014 · Food Chemistry
  84. Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells
    Lars Tögel, Rebecca Nightingale, Anderly C. Chüeh, Aparna Jayachandran, Hoanh Tran, Toby James Phesse, Rui Wu, Oliver M. Sieber, Diego Arango, Amardeep S. Dhillon et al. · 2016 · Molecular Cancer Therapeutics
  85. MYC Modulation around the CDK2/p27/SKP2 Axis
    Per Hydbring, Alina Castell, Lars‐Gunnar Larsson · 2017 · Genes
  86. Identification of a potent and selective covalent Pin1 inhibitor
    Benika J. Pinch, Zainab M. Doctor, Behnam Nabet, Christopher M. Browne, Hyuk‐Soo Seo, Mikaela L. Mohardt, Shingo Kozono, Xiaolan Lian, Theresa D. Manz, Yujin Chun et al. · 2020 · Nature Chemical Biology
  87. Myc as a Regulator of Ribosome Biogenesis and Cell Competition: A Link to Cancer
    Francesca Destefanis, Valeria Manara, Paola Bellosta · 2020 · International Journal of Molecular Sciences
  88. Post-Transcriptional Control of LINE-1 Retrotransposition by Cellular Host Factors in Somatic Cells
    Javier G. Pizarro, Gaël Cristofari · 2016 · Frontiers in Cell and Developmental Biology
  89. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer’s disease
    Takahashi, K., Uchida, C., Shin, R.-W., Shimazaki, K., Uchida, T. · 2008 · Cellular and Molecular Life Sciences
  90. HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance
    Kideok Jin, Sunju Park, Wei Wen Teo, Preethi C. Korangath, Sean Soonweng Cho, Takahiro Yoshida, Balázs Győrffy, Chirayu Pankaj Goswami, Harikrishna Nakshatri, Leigh-Ann Cruz et al. · 2015 · Cancer Discovery
  91. A Novel, Immortal, and Multipotent Human Neural Stem Cell Line Generating Functional Neurons and Oligodendrocytes
    Lidia De Filippis, Giuseppe Lamorte, Evan Y. Snyder, Antonio Malgaroli, Angelo Luigi Vescovi · 2007 · Stem Cells
  92. Prolyl isomerases in gene transcription
    Steven D. Hanes · 2014 · Biochimica et Biophysica Acta (BBA) - General Subjects
  93. Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas
    Phuoc Tho Tran, Alice C. Fan, Pavan K. Bendapudi, Shan Koh, K.M. Komatsubara, Joy Chen, George Horng, David I. Bellovin, Sylvie Giuriato, Craig S. Wang et al. · 2008 · PLoS ONE
  94. Regulation of the Ring Finger E3 Ligase Siah2 by p38 MAPK
    Ashwani Khurana, Koh Nakayama, Scott Williams, Roger J. Davis, Tomas Mustelin, Ze’ev A. Ronai · 2006 · Journal of Biological Chemistry
  95. Genetic Modeling of Human Rhabdomyosarcoma
    Corinne Mary Linardic, Diane L. Downie, Stephen J. Qualman, Rex C. Bentley, Christopher M. Counter · 2005 · Cancer Research
  96. Sensing and Integration of Erk and PI3K Signals by Myc
    Tae Lee, Guang Yao, Joseph Roy Nevins, Lingchong You · 2008 · PLoS Computational Biology
  97. Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
    Sarasija Naini, Katherine T. Etheridge, Stacey J. Adam, Stephen J. Qualman, Rex C. Bentley, Christopher M. Counter, Corinne Mary Linardic · 2008 · Cancer Research
  98. Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1)
    Ping Yi, Ray‐Chang Wu, Joshua C. Sandquist, Jiemin Wong, Sophia Y. Tsai, Ming‐Jer Tsai, Anthony R. Means, Bert W. O’Malley · 2005 · Molecular and Cellular Biology
  99. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma
    Allen-Petersen, Brittany L., Risom, Tyler, Feng, Zipei, Wang, Zhiping, Jenny, Zina P., Thoma, Mary C., Pelz, Katherine R., Morton, Jennifer P., Sansom, Owen J., Lopez, Charles D. et al. · 2019 · Cancer Research
  100. MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals
    Francesco Marampon, Giovanni Luca Gravina, Agnese Di Rocco, Pierluigi Bonfili, Mario Di Staso, Caterina Fardella, Lorella Polidoro, Carmela Ciccarelli, Claudio Festuccia, Vladimir M. Popov et al. · 2011 · Molecular Cancer Therapeutics